Does Helicobacter pylori infection affect indirect hepatic fibrosis tests?
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Helicobacter pylori infection does not affect the accuracy of non-invasive liver fibrosis tests, including the AST-to-Platelet Ratio Index (APRI) and Fibrosis-4 (FIB-4) score. These biochemical markers remain reliable for assessing liver fibrosis regardless of H. pylori status.
Area Of Science
- Hepatology
- Gastroenterology
- Biochemistry
Background
- Early detection of chronic liver disease fibrosis is vital for patient prognosis.
- Non-invasive biochemical tests like APRI and FIB-4 are used for fibrosis evaluation.
- The impact of Helicobacter pylori (H. pylori) on these fibrosis tests is not well understood.
Purpose Of The Study
- To investigate the influence of H. pylori infection on the accuracy of APRI and FIB-4 scores in assessing liver fibrosis.
Main Methods
- 190 adult patients with gastric and liver biopsies were analyzed.
- Patients were grouped by fibrosis severity (mild, moderate, advanced) and H. pylori status.
- Demographic, clinical, laboratory, and histopathological data were compared.
Main Results
- H. pylori was present in 71% of patients.
- No significant differences in APRI or FIB-4 scores were found between H. pylori-positive and negative groups.
- APRI and FIB-4 scores showed significant differences across fibrosis severity groups, independent of H. pylori presence.
Conclusions
- H. pylori infection does not significantly affect APRI and FIB-4 scores.
- APRI and FIB-4 are reliable tools for assessing liver fibrosis, irrespective of H. pylori status.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Location of Pain:...
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Technological Integration: EUS is a sophisticated integration of optical endoscopy and ultrasonography. The endoscope visualizes the mucosal surface directly, while the ultrasound component penetrates deeper to visualize organs and structures beyond the gastrointestinal wall.
Image Formation: The ultrasound...
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...